Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

HALOZYME THERAPEUTICS, INC. (HALO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues          
Total revenues  443.3267.6196.0151.9316.6146.7135.175.3
            Total revenues growth  65.7%36.5%29.1%-52.0%115.8%8.6%79.3%37.5%
Operating expenses          
Cost of sales  81.443.445.510.131.2   
Research and development  35.734.2140.8150.3150.6150.893.279.7
Selling, general and administrative  50.345.777.360.853.845.940.035.9
    Total operating expenses  167.4123.3263.6221.2235.6229.9162.5138.4
    Operating income  275.9144.3-67.6-69.381.0-83.2-27.5-63.0
            Operating margin  62.2%53.9%-34.5%-45.7%25.6%-56.7%-20.3%-83.7%
   
Other income (expense)          
Investment and other income (expense), net  1.15.47.07.62.61.30.4 
Interest expense  -7.5-20.4-11.6-18.0-22.0-20.0-5.2-5.6
    Net income before income taxes  248.5129.3-72.3-79.861.6-101.9-32.2-68.4
Income tax expense  -154.20.20.00.5-1.41.2  
    Net income  402.7129.1-72.2-80.363.0-103.0-32.2-68.4
   
Earnings per share          
Basic (USD per share)  $2.86$0.95($0.50)($0.56)$0.46($0.81)($0.25)($0.56)
Diluted (USD per share)  $2.74$0.91($0.50)($0.56)$0.45($0.81)($0.25)($0.56)
   
Weighted average common shares outstanding          
Basic (shares)  140.6136.2144.3143.6136.4128.0126.7122.7
Diluted (shares)  146.8141.5144.3143.6139.1128.0126.7122.7

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy